Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection.

To determine the role of surfactant protein-A (SP-A) in host defense, the murine SP-A locus was targeted by homologous recombination to produce mice lacking SP-A. SP-A-/- and wild-type mice were infected with mucoid Pseudomonas aeruginosa by intratracheal instillation. Pulmonary bacterial loads were greater in SP-A-/- than in wild-type mice, with increased numbers of mucoid P. aeruginosa in lung homogenates at 6 and 24 h after infection. Pulmonary infiltration with polymorphonuclear leukocytes (PMN) was similar in both groups; however, an earlier influx of PMN into the lung occurred in the SP-A-/- mice. The number of bacteria phagocytosed by alveolar macrophages was decreased in the SP-A-/- mice at 1 h after infection. Superoxide-radical generation by PMN was similar for the SP-A-/- and wild-type mice, but nitrite levels were increased in SP-A-/- mice. Concentrations of tumor necrosis factor-alpha, interleukin-6, and macrophage inflammatory protein-2 (proinflammatory cytokines) were greater in bronchoalveolar lavage fluid at 2 h after infection in SP-A-/- mice. SP-A plays an important role in the pathogenesis of mucoid P. aeruginosa infection in the lung in vivo by enhancing macrophage phagocytosis and clearance of bacteria, and by modifying the inflammatory response.

[1]  W. Watford,et al.  Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. , 1999, American journal of respiratory cell and molecular biology.

[2]  D. Corry,et al.  IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. , 1997, Journal of immunology.

[3]  M. Griese,et al.  Pulmonary surfactant in cystic fibrosis. , 1997, The European respiratory journal.

[4]  W. Martin,et al.  Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages. , 1997, American journal of respiratory cell and molecular biology.

[5]  F. Fang Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. , 1997, The Journal of clinical investigation.

[6]  F. Fang Mechanisms of nitric oxide-related antimicrobial activity , 1997 .

[7]  H. Blau,et al.  Nitric oxide production by rat alveolar macrophages can be modulated in vitro by surfactant protein A. , 1997, The American journal of physiology.

[8]  J. Whitsett,et al.  Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. , 1997, Journal of immunology.

[9]  S. Kremlev,et al.  Surfactant protein A regulates cytokine production in the monocytic cell line THP-1. , 1997, The American journal of physiology.

[10]  I. Ofek,et al.  SP-A enhances phagocytosis of Klebsiella by interaction with capsular polysaccharides and alveolar macrophages. , 1997, The American journal of physiology.

[11]  B. Stripp,et al.  Altered surfactant function and structure in SP-A gene targeted mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Wright,et al.  Surfactant protein A protects growing cells and reduces TNF-alpha activity from LPS-stimulated macrophages. , 1996, The American journal of physiology.

[13]  M. Pollack,et al.  Surfactant content in children with inflammatory lung disease. , 1996, Critical care medicine.

[14]  W. Chao,et al.  Inhibition of the human neutrophil respiratory burst by native and synthetic surfactant. , 1996, American journal of respiratory cell and molecular biology.

[15]  R. Wunderink,et al.  Ventilator-associated pneumonia due to Pseudomonas aeruginosa. , 1996, Chest.

[16]  D. Voelker,et al.  Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. , 1995, Journal of immunology.

[17]  H. Plattner,et al.  Lung surfactant protein A (SP-A) activates a phosphoinositide/calcium signaling pathway in alveolar macrophages. , 1995, Journal of cell science.

[18]  T. Standiford,et al.  Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. , 1995, Journal of immunology.

[19]  W. Voorhout,et al.  Opsonic activities of surfactant proteins A and D in phagocytosis of gram-negative bacteria by alveolar macrophages. , 1995, The Journal of infectious diseases.

[20]  S. Kremlev,et al.  Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. , 1994, The American journal of physiology.

[21]  M. Daha,et al.  Binding of surfactant protein A to C1q receptors mediates phagocytosis of Staphylococcus aureus by monocytes. , 1994, The American journal of physiology.

[22]  J. Coonrod,et al.  Aggregation and opsonization of type A but not type B Hemophilus influenzae by surfactant protein A. , 1994, American journal of respiratory cell and molecular biology.

[23]  J. Wright,et al.  Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. , 1993, The American journal of physiology.

[24]  J. Whitsett,et al.  Decreased surfactant protein A in patients with bacterial pneumonia. , 1993, The American review of respiratory disease.

[25]  R. Ezekowitz,et al.  Collectins: pattern recognition molecules involved in first line host defense. , 1993, Current opinion in immunology.

[26]  Coonrod Jd,et al.  Comparison of the Opsonic Activity of Human Surfactant Protein A for Staphylococcus aureus and Streptococcus pneumoniae with Rabbit and Human Macrophages , 1993 .

[27]  J. Coonrod,et al.  Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages. , 1993, The Journal of infectious diseases.

[28]  E. Crouch,et al.  Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. , 1992, The Journal of clinical investigation.

[29]  J. Wright,et al.  Specific binding of surfactant apoprotein SP-A to rat alveolar macrophages. , 1992, The American journal of physiology.

[30]  H. Plattner,et al.  Lung surfactant protein A (SP-A) enhances serum-independent phagocytosis of bacteria by alveolar macrophages. , 1992, European journal of cell biology.

[31]  M. Berger Inflammation in the lung in cystic fibrosis , 1991, Clinical Reviews in Allergy.

[32]  J. Verhoef Host-pathogen relationships in respiratory tract infections. , 1991, Clinical therapeutics.

[33]  M. Berger Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good? , 1991, Clinical reviews in allergy.

[34]  R. Rodríguez-Roisín,et al.  Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. , 1990, The American review of respiratory disease.

[35]  S. Thiel,et al.  Human leukocyte C1q receptor binds other soluble proteins with collagen domains , 1990, The Journal of experimental medicine.

[36]  R. Dessau,et al.  In Vivo and In Vitro Antibacterial Activity of Conglutinin, a Mammalian Plasma Lectin , 1990, Scandinavian journal of immunology.

[37]  J. Verhoef,et al.  Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. , 1990, American journal of respiratory cell and molecular biology.

[38]  S. Thiel,et al.  ASSOCIATION OF LOW LEVELS OF MANNAN-BINDING PROTEIN WITH A COMMON DEFECT OF OPSONISATION , 1989, The Lancet.

[39]  J. Wright,et al.  Lung surfactant apoprotein SP-A (26-36 kDa) binds with high affinity to isolated alveolar type II cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Kenneth Reid,et al.  Structures and functions associated with the group of mammalian lectins containing collagen‐like sequences , 1989, FEBS letters.

[41]  J. Groopman,et al.  A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus , 1989, The Journal of experimental medicine.

[42]  S. Wright,et al.  Functional characterization of macrophage receptors for in vitro phagocytosis of unopsonized Pseudomonas aeruginosa. , 1988, The Journal of clinical investigation.

[43]  W. Busse,et al.  Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. , 1988, The Journal of allergy and clinical immunology.

[44]  C. Bryan,et al.  Bacteremic nosocomial pneumonia. Analysis of 172 episodes from a single metropolitan area. , 2015, The American review of respiratory disease.

[45]  G. Bodey,et al.  Infections caused by Pseudomonas aeruginosa. , 1983, Reviews of infectious diseases.

[46]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[47]  E. Goldstein,et al.  Murine pulmonary alveolar macrophages: rates of bacterial ingestion, inactivation, and destruction. , 1976, The Journal of infectious diseases.